animal model to identify therapeutically useful compounds for the treatment of amyotrophic lateral sclerosis sporadic

摘要

animal model to identify therapeutically useful compounds for the treatment of sporadic amyotrophic lateral sclerosis. # The present invention relates to a method for the identification of potentially useful compounds for the treatment of Amyotrophic Lateral Sclerosis (ALS) sporadic comprising employing an animal model rats developed by administering be {} -N-methylamino-L-alanine (L-BMAA).